- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Myelodysplastic Syndrome in United Kingdom
Total 15568 results
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
CelgeneCompletedLeukemia, Myelomonocytic, Juvenile | Myelodysplastic SyndromeSpain, Germany, Italy, United Kingdom, Belgium, France, Denmark, Netherlands, Sweden, Switzerland, Austria, Czechia, Ireland
-
NovaceaUnknownMyelodysplastic SyndromeUnited States
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Washington University School of MedicineAmerican Society of HematologyRecruitingMyelodysplastic Syndromes | Whole Genome SequencingUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedMyelodysplastic SyndromesUnited States
-
Ehab L AtallahCompleted
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Celgene CorporationCompletedMyelodysplasiaUnited States
-
TelikCompletedMyelodysplastic SyndromeUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAcute Myelogenous Leukemia | High-Grade Myelodysplastic SyndromeUnited States
-
Janssen Research & Development, LLCActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited Kingdom, France, Korea, Republic of, Spain
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
Duke UniversityBayerTerminatedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited States
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Hoffmann-La RocheCompletedMyelodysplastic SyndromesUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromesUnited States, France, Germany
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
Massachusetts General HospitalNovartisRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic Syndrome With Isolated Del(5q)United States
-
Janssen Research & Development, LLCCompletedMyelodysplastic SyndromesUnited States, Belgium, Italy, Spain, Netherlands, Russian Federation
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterGlaxoSmithKline; NovartisCompleted
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownMyelodysplastic Syndromes | AdultBelgium, United States, Austria, United Kingdom, Italy, Taiwan, Brazil, China, Croatia, Czechia, France, Germany
-
Office of Rare Diseases (ORD)Rare Diseases Clinical Research NetworkUnknownMyelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic SyndromesChina, Hong Kong, Switzerland, United Kingdom, Italy, Thailand, Bulgaria, Greece, Russian Federation, Canada, Mexico, Australia, Denmark, Malaysia, New Zealand, United States
-
National Cancer Institute (NCI)Active, not recruiting
-
Gemin XCompletedMyelodysplastic SyndromesCanada, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic... and other conditionsUnited States
-
Yale UniversityWithdrawn
-
OHSU Knight Cancer InstituteOregon Health and Science University; Oryzon Genomics S.A.Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome/Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Baylor Research InstituteGenzyme, a Sanofi CompanyCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterEisai Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Janssen Research & Development, LLCTerminatedMyelodysplastic SyndromeUnited States, Belgium, Spain, Australia, Sweden, Netherlands, Russian Federation
-
Patrick StiffRecruitingMyelodysplastic Syndrome MDS | Acute Myelogenous Leukemia AMLUnited States